Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Identification of electrical grid phase information for end-points in a grid network
Adaptive non-positive inductor current detector (ANPICD)
Determining ill conditioning in square linear system of equations
Squib control circuit
Multi-room user interface
Memory device program window adjustment
Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
  Randomly Featured Patents
Laser-based glass thickness measurement system and method
Endoscopic stapler
Polyketone fiber and process for producing the same
Image reading apparatus and light source stability determination method
Controller interface with separate schedule review mode
Method for preparing raw pollen
Strap tenser
Method and apparatus to facilitate variable-rate call management operations
Device for gripping necks of packed sacks